You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Eli Lilly announces Q4 dividend
20 October 2020 -

Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, has announced its dividend for the fourth quarter of 2020, it was reported on Monday.

The company has declared dividend of USD0.74 per share on outstanding common stock.

The dividend will be paid to shareholders of record at 13 November 2020 on 10 December 2020.

Login
Username:

Password:


Related Headlines

Bavarian Nordic secures USD143.6m US government contract for freeze-dried smallpox/mpox vaccine supply

Lilly declares Q2 2025 dividend

Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics

Emmaus Life Sciences reports drop in revenues, increased loss in 2024

L'Oréal and WHO Foundation partner to expand global skin health access

Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion

ANI Pharmaceuticals announces buyout of royalty obligation for ILUVIEN and YUTIQ

Sirum collaborates with Governor Wes Moore to expand medication access across Maryland

Genomma Lab Internacional announces quarterly dividend

Abbott announces quarterly common dividend

West Pharmaceutical Services announces Q2 dividend

Perrigo increases quarterly dividend

AbbVie announces quarterly cash dividend

hVIVO acquires German Clinical Research Units for EUR10m; Targets earnings growth by 2026

OptiBiotix expands into Indian market with Amazon launch

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2025